Cocrystal Pharma (NASDAQ: COCP) Extends Enrollment in Phase 2a Influenza StudyCocrystal Pharma, Inc., a clinical-stage biotechnology company, has announced plans to extend enrollment in the Phase 2a human challenge study for its oral influenza PB2 in
This article was generated by an automated content engine and was reviewed by a human editor prior to publication. For additional information, read Cocrystal Pharma’s...
Cocrystal Pharma (NASDAQ: COCP) Extends Enrollment in Phase 2a Influenza StudyCocrystal Pharma, Inc., a clinical-stage biotechnology company, has announced plans to extend enrollment in the Phase 2a human challenge study for its oral influenza PB2 in
This article was generated by an automated content engine and was reviewed by a human editor prior to publication. For additional information, read Cocrystal Pharma’s...
Adtalem Global Education Inc. (NYSE:ATGE) Sees Significant Increase in Short Interest
Adtalem Global Education Inc. (NYSE:ATGE – Get Free Report) was the target of a significant increase in short interest during the month of December. As...
Adtalem Global Education Inc. (NYSE:ATGE) Sees Significant Increase in Short Interest
Adtalem Global Education Inc. (NYSE:ATGE – Get Free Report) was the target of a significant increase in short interest during the month of December. As...
Rocket Companies (NYSE:RKT) Sets New 12-Month Low – Here’s What Happened
Rocket Companies, Inc. (NYSE:RKT – Get Free Report) shares hit a new 52-week low on Monday . The company traded as low as $10.78 and...
Rocket Companies (NYSE:RKT) Sets New 12-Month Low – Here’s What Happened
Rocket Companies, Inc. (NYSE:RKT – Get Free Report) shares hit a new 52-week low on Monday . The company traded as low as $10.78 and...